Voriconazole versus liposomal amphotericin B for empirical antifungal therapy [1] (multiple letters)

James R. Johnson, Andrew J. Ullmann, Claus Peter Heussel, Oliver A. Cornely, Anucha Apisarnthanarak, J. Russell Litlle, Pablo Tebas, Thomas J. Walsh, Peter G. Pappas, Drew J. Winston

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)1745-1747
Number of pages3
JournalNew England Journal of Medicine
Volume346
Issue number22
DOIs
StatePublished - May 30 2002

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Johnson, J. R., Ullmann, A. J., Heussel, C. P., Cornely, O. A., Apisarnthanarak, A., Litlle, J. R., Tebas, P., Walsh, T. J., Pappas, P. G., & Winston, D. J. (2002). Voriconazole versus liposomal amphotericin B for empirical antifungal therapy [1] (multiple letters). New England Journal of Medicine, 346(22), 1745-1747. https://doi.org/10.1056/NEJM200205303462213